Elevance Health expects FY2026 adjusted earnings of at least $29 per diluted share
ELV•Elevance Health expects FY2026 adjusted earnings of at least $29 per diluted share and reaffirmed its benefit expense ratio guidance of 90.2%, plus or minus 50 basis points.
1. FY2026 outlook
Elevance Health said in an SEC filing that it expects FY2026 adjusted earnings of at least $29 per diluted share. The company reaffirmed its FY2026 benefit expense ratio guidance of 90.2%, plus or minus 50 basis points.
